Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

A consensus statement regarding the utilization of BMP in spine surgery.

Walker B, Koerner J, Sankarayanaryanan S, Radcliff K.

Curr Rev Musculoskelet Med. 2014 Sep;7(3):208-19. doi: 10.1007/s12178-014-9224-0.

2.

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.

Carragee EJ, Hurwitz EL, Weiner BK.

Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023. Review.

PMID:
21729796
4.

Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.

Crawford CH 3rd, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD.

Spine (Phila Pa 1976). 2009 Jun 1;34(13):1390-4. doi: 10.1097/BRS.0b013e3181a2da08.

PMID:
19440166
5.

Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature.

Singh K, Ahmadinia K, Park DK, Nandyala SV, Marquez-Lara A, Patel AA, Fineberg SJ.

Spine (Phila Pa 1976). 2014 Jan 1;39(1):91-101. doi: 10.1097/BRS.0000000000000004. Review.

PMID:
24026158
6.
7.

Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.

Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK.

Spine J. 2004 Sep-Oct;4(5):527-38; discussion 538-9.

PMID:
15363423
8.

Complications related to osteobiologics use in spine surgery: a systematic review.

Mroz TE, Wang JC, Hashimoto R, Norvell DC.

Spine (Phila Pa 1976). 2010 Apr 20;35(9 Suppl):S86-104. doi: 10.1097/BRS.0b013e3181d81ef2. Review.

PMID:
20407355
9.

Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.

Hofstetter CP, Hofer AS, Levi AD.

J Neurosurg Spine. 2016 Mar;24(3):457-75. doi: 10.3171/2015.4.SPINE141086. Epub 2015 Nov 27.

PMID:
26613283
10.

Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.

Singh K, Nandyala SV, Marquez-Lara A, Fineberg SJ.

Spine (Phila Pa 1976). 2014 Mar 15;39(6):491-6. doi: 10.1097/BRS.0000000000000167.

PMID:
24365905
11.

Use of bone morphogenetic protein-2 for adult spinal deformity.

Luhmann SJ, Bridwell KH, Cheng I, Imamura T, Lenke LG, Schootman M.

Spine (Phila Pa 1976). 2005 Sep 1;30(17 Suppl):S110-7.

PMID:
16138058
12.

Off-label use of bone morphogenetic proteins in the United States using administrative data.

Ong KL, Villarraga ML, Lau E, Carreon LY, Kurtz SM, Glassman SD.

Spine (Phila Pa 1976). 2010 Sep 1;35(19):1794-800. doi: 10.1097/BRS.0b013e3181ecf6e4.

PMID:
20700081
13.

RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.

Kim HJ, Buchowski JM, Zebala LP, Dickson DD, Koester L, Bridwell KH.

Spine (Phila Pa 1976). 2013 Jun 15;38(14):1209-15. doi: 10.1097/BRS.0b013e31828b656d.

PMID:
23392417
14.

A review of the current published spinal literature regarding bone morphogenetic protein-2: an insight into potential bias.

Skovrlj B, Marquez-Lara A, Guzman JZ, Qureshi SA.

Curr Rev Musculoskelet Med. 2014 Sep;7(3):182-8. doi: 10.1007/s12178-014-9221-3.

15.

Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases.

Lewandrowski KU, Nanson C, Calderon R.

Spine J. 2007 Sep-Oct;7(5):609-14. Epub 2007 May 7.

PMID:
17526434
16.

Reoperation rates for symptomatic nonunions in posterior cervical (subaxial) fusions with and without bone morphogenetic protein in a cohort of 1158 patients.

Guppy KH, Harris J, Chen J, Paxton EW, Alvarez J, Bernbeck J.

J Neurosurg Spine. 2016 Apr;24(4):556-64. doi: 10.3171/2015.7.SPINE15353. Epub 2016 Jan 1.

PMID:
26722955
17.

Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.

Rahman RK, Buchowski JM, Stephens B, Dorward IG, Koester LA, Bridwell KH.

Spine (Phila Pa 1976). 2013 Dec 15;38(26):2264-71. doi: 10.1097/BRS.0000000000000045.

PMID:
24108280
18.

Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Faundez A, Tournier C, Garcia M, Aunoble S, Le Huec JC.

Int Orthop. 2016 Jun;40(6):1309-19. doi: 10.1007/s00264-016-3149-8. Epub 2016 Mar 10. Review.

PMID:
26961193
19.

Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?

Guzman JZ, Merrill RK, Kim JS, Overley SC, Dowdell JE, Somani S, Hecht AC, Cho SK, Qureshi SA.

Spine J. 2017 Apr 26. pii: S1529-9430(17)30187-0. doi: 10.1016/j.spinee.2017.04.030. [Epub ahead of print]

PMID:
28456674
20.

Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.

Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M.

Ann Intern Med. 2013 Jun 18;158(12):890-902. doi: 10.7326/0003-4819-158-12-201306180-00006. Review.

PMID:
23778906

Supplemental Content

Support Center